What is the official website of Roche Bangladesh ?

The official website of Roche Bangladesh is https://www.roche.com.bd/.

What is Roche Bangladesh's cybersecurity risk score?

Roche Bangladesh has an AI-generated cybersecurity risk score of 756 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Roche Bangladesh experienced?

According to Rankiteo, Roche Bangladesh currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Roche Bangladesh been affected by any supply chain cyber incidents ?

According to Rankiteo, Roche Bangladesh has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Roche Bangladesh have SOC 2 Type 1 certification ?

According to Rankiteo, Roche Bangladesh is not certified under SOC 2 Type 1.

Does Roche Bangladesh have SOC 2 Type 2 certification ?

According to Rankiteo, Roche Bangladesh does not hold a SOC 2 Type 2 certification.

Does Roche Bangladesh comply with GDPR ?

According to Rankiteo, Roche Bangladesh is not listed as GDPR compliant.

Does Roche Bangladesh have PCI DSS certification ?

According to Rankiteo, Roche Bangladesh does not currently maintain PCI DSS compliance.

Does Roche Bangladesh comply with HIPAA ?

According to Rankiteo, Roche Bangladesh is not compliant with HIPAA regulations.

Does Roche Bangladesh have ISO 27001 certification ?

According to Rankiteo,Roche Bangladesh is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Roche Bangladesh operate in ?

Roche Bangladesh operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Roche Bangladesh have ?

Roche Bangladesh employs approximately None employees people worldwide.

Does Roche Bangladesh own any subsidiaries ?

Roche Bangladesh presently has no subsidiaries across any sectors.

How many LinkedIn followers does Roche Bangladesh have ?

Roche Bangladesh's official LinkedIn profile has approximately 10,877 followers.

What is the NAICS classification code for Roche Bangladesh ?

Roche Bangladesh is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Roche Bangladesh have a Crunchbase profile ?

No, Roche Bangladesh does not have a profile on Crunchbase.

Does Roche Bangladesh have a LinkedIn profile ?

Yes, Roche Bangladesh maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/roche-bangladesh.

How many cybersecurity incidents has Roche Bangladesh experienced ?

As of October 4, 2026, Rankiteo reports that Roche Bangladesh has not experienced any cybersecurity incidents.

How many peer or competitor companies does Roche Bangladesh have ?

Roche Bangladesh has an estimated 5,772 peer or competitor companies worldwide.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Roche Bangladesh

Boost Score +25 with badge (5 left)

756

/1000

Fair

781

/1000

Fair

Roche Bangladesh Vendor Cyber Rating & Cyber Score

roche.com.bd

Add Your Compliance Badge

Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Our personalized healthcare strategy aims at providing medicines that enable tangible improvements in the health, quality of life and survival of patients. 31 medicines developed by Roche are included in the WHO Model Lists of Essential Medicines. Twenty-five of these are patent-free and include life-saving antibiotics, anti-malarials and chemotherapy. We have been at the forefront of cancer research and treatment for over 50 years, with medicines for breast, skin, colon, ovarian, lung and numerous other cancers. Roche Bangladesh Limited is an affiliate

Roche Bangladesh

Roche Bangladesh CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

Roche Bangladesh Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Roche Bangladesh

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Roche Bangladesh in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Roche Bangladesh in 2026.

Incident Types Roche Bangladesh vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Roche Bangladesh in 2026.

Incident History - Roche Bangladesh (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Roche Bangladesh Subsidiaries

Roche Bangladesh

Pharmaceutical Manufacturing

Website: https://www.roche.com.bd/

Company Size: 11-50 employees

Roche MéxicoPharmaceutical Manufacturing

RocheBiotechnology Research

Roche EcuadorFabricación de productos farmacéuticos

Roche ArgentinaFabricación de productos farmacéuticos

Roche Diagnostics USABiotechnology Research

Loading…

Roche Bangladesh Similar Companies

Hikma Pharmaceuticals

cb hikma.com

For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists need to treat their patients across North America, MENA and Europe. We have 29 manufacturing plants, 3 R&D hubs and c9,500 employees worldwide. *As of December 2025 Subscribe to our channel on YouTube https://youtube.com/@hikmapharmaceuticals5668 For all product information and enquiries, please contact us at [email protected]

Dr. Reddy's Laboratories

drreddys.com

Established in 1984, we are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’, we work to provide access to affordable and innovative medicines. We offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major markets include USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in future growth drivers such as access to novel molecules, digital therapeutics and consumer healthcare. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: www.drreddys.com. Caution Notice: Dr. Reddy's has been made aware of candidates receiving fraudulent job opportunities from unauthorised recruiting agencies or people impersonating Dr. Reddy's leaders. These fraudulent jobs may be advertised on employment sites or mimic our careers site and company email addresses. Please know that Dr. Reddy's Laboratories has no affiliation or connection to these situations. Dr. Reddy's (and its associated/group companies) follows a formal recruitment process through its own HR department. Please report immediately in case you suspect a fraudulent job. You may raise your concern by: Accessing https://drreddys.ethicspoint.com. Calling on the hotline number. List of hotline numbers are available in https://drreddys.ethicspoint.com. The hotline is available 24x7 in multiple languages. Writing to [email protected] or [email protected]. For our community guidelines on LinkedIn, please visit: https://shorturl.at/LTvNZ

MACLEODS PHARMACEUTICALS LTD.

macleodspharma.com

A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment. We develop, manufacture, and globally distribute a broad range of pharmaceutical products across therapies in multiple dosage forms such as solid orals, liquid orals, topical formulations, injectables (Dry Powder) metered dose inhalers and dry powder inhalers. Our Vision To be a leading global pharmaceutical company by providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs. Our Mission To contribute towards improving patients’ quality of life across the globe, by providing effective and accessible medicines.

Servier

servier.com

Servier is an independent international pharmaceutical group governed by a foundation. With its unique governance model, the Group is committed to therapeutic progress to serve patients and integrates the patient voice at every stage of the medicine life cycle. As a leading global player in cardiology and venous diseases, Servier aims to become a leading innovator in oncology and neurology. Through precision medicine, the Group intends to offer targeted therapeutic solutions for a limited number of rare diseases and invests nearly 20% of its brand-name sales in R&D. Headquartered in France, Servier relies on its more than 20,000 employees and a solid geographic presence with medicines distributed in more than 130 countries. In the 2024/25 financial year, the Group achieved revenues of €6.9 billion. -- To report a suspected adverse event with a Servier drug, please visit servier.com

AbbVie

cb abbvie.com

AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.

Astellas Pharma

astellas.com

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines

MSD

msd.com

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on Facebook, Instagram, Twitter, and YouTube.

Parexel

parexel.com

Parexel is a leading global clinical research organization (CRO) providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry. Leveraging deep local knowledge and a global breadth of clinical, regulatory and therapeutic expertise, our 24,000+ professionals worldwide work in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind — broadening access and making clinical research a care option for anyone, anywhere. Our proven track record spans 40+ years and drives us forward, advancing clinical research in healthcare’s most complex areas while harnessing innovation to drive efficiencies across every phase of the clinical development process. Our insights-driven approach, proven delivery and trusted execution are accelerating the delivery of life-changing treatments to patients — With Heart.™ We continue to earn recognition industrywide, including the 2025 Scrip Award for “Best Contract Research Organization – Full-Service Provider,” 2024 Fierce Biotech CRO Award for "Innovative Approaches to Patient-Centric Research" and the 2024 and 2023 Society for Clinical Research Sites (SCRS) Eagle Award. Community Guidelines Because Parexel’s social media channels are open to the general public and employees, we are not responsible for views expressed other than our own. However, we do not tolerate posts that are: • Abusive, harassing or threatening to others. • Defamatory, offensive, obscene, vulgar or depicting violence. • Hateful targeting by race/ethnicity, age, color, creed, religion, gender, sexual preference or orientation, nationality or political beliefs. • Sexually explicit or pornographic. • Fraudulent, deceptive, libelous, misleading or unlawful. • Referencing criminal or illegal activity. • Spamming. We reserve the right to remove comments that do not adhere to our guidelines and report users who violate the rules of our page.

Bristol Myers Squibb

cb bms.com

At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html

Loading…

NEWS

Roche Bangladesh CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

March 12, 2021 06:00 AM

Roche looks to serving more cancer patients in Bangladesh

Adriano Antonio Treve, Area Head, Roche Central Eastern Europe, Turkey, Russia and Indian Subcontinent, recently visited Bangladesh.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-96451

SUMMARY

Authorization Bypass Through User-Controlled Key vulnerability in Ultimate Member Ultimate Member ultimate-member allows Privilege Escalation.This issue affects Ultimate Member: from n/a through 2.13.1.

Published

Date2026-10-03

Updated

Date2026-10-03

RISK INFORMATION (Score: 8.8)

cvss3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

2.8

REFERENCES

https://patchstack.com/database/wordpress/plugin/ultimate-member/vulnerability/wordpress-ultimate-member-plugin-2-13-1-privilege-escalation-vulnerability?_s_id=cve

CVE-2026-103342

SUMMARY

Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Unlimited Elements Unlimited Elements For Elementor (Free Widgets, Addons, Templates) unlimited-elements-for-elementor allows Reflected XSS.This issue affects Unlimited Elements For Elementor (Free Widgets, Addons, Templates): from n/a through 2.0.20.

Published

Date2026-10-03

Updated

Date2026-10-03

RISK INFORMATION (Score: 7.1)

cvss3

Base Score: 7.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:L

Impact Score

3.7

Exploitability

2.8

REFERENCES

https://patchstack.com/database/wordpress/plugin/unlimited-elements-for-elementor/vulnerability/wordpress-unlimited-elements-for-elementor-free-widgets-addons-templates-plugin-2-0-20-cross-site-scripting-xss-vulnerability?_s_id=cve

CVE-2026-103065

SUMMARY

Improper Validation of Specified Quantity in Input vulnerability in Themeum Kirki kirki allows Accessing Functionality Not Properly Constrained by ACLs.This issue affects Kirki: from n/a through 6.3.1.

Published

Date2026-10-03

Updated

Date2026-10-03

RISK INFORMATION (Score: 8.2)

cvss3

Base Score: 8.2

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:L/A:N

Impact Score

4.2

Exploitability

3.9

REFERENCES

https://patchstack.com/database/wordpress/plugin/kirki/vulnerability/wordpress-kirki-plugin-6-3-1-arbitrary-code-execution-vulnerability?_s_id=cve

CVE-2026-105122

SUMMARY

OpenAM before 16.1.3 contains a server-side request forgery vulnerability that allows attackers able to register or modify OAuth 2.0 clients to make OpenAM fetch internal resources via an unvalidated jwks_uri. Attackers can trigger unauthenticated fetches through client-authentication and ID-token validation to probe internal hosts, metadata endpoints or local files, or exhaust request threads for denial of service.

Published

Date2026-10-03

Updated

Date2026-10-03

RISK INFORMATION (Score: 5.4)

cvss3

Base Score: 5.4

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:L

cvss4

Base Score: 5.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

2.5

Exploitability

2.8

REFERENCES

CVE-2026-105121

SUMMARY

OpenAM before 16.1.3 contains an improper authorization vulnerability that allows delegated administrators to destroy sessions outside their realms because realm checks use the requester's realm. Authenticated accounts holding the iplanet-am-session-destroy-sessions attribute can supply a target session identifier or handle to forcibly log out users in any realm.

Published

Date2026-10-03

Updated

Date2026-10-03

RISK INFORMATION (Score: 4.9)

cvss3

Base Score: 4.9

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:N/I:N/A:H

cvss4

Base Score: 6.9

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

1.2

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Roche Bangladesh Vendor Cyber Rating & Cyber Score

Roche Bangladesh A.I CyberSecurity Scoring

Roche Bangladesh CyberSecurity News & History

Roche Bangladesh Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Roche Bangladesh

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Roche Bangladesh vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - Roche Bangladesh (X = Date, Y = Severity)

Roche Bangladesh Subsidiaries

Roche Bangladesh

Roche Bangladesh Similar Companies

Hikma Pharmaceuticals

Dr. Reddy's Laboratories

MACLEODS PHARMACEUTICALS LTD.

Servier

AbbVie

Astellas Pharma

MSD

Parexel

Bristol Myers Squibb

Roche Bangladesh CyberSecurity News

Roche looks to serving more cancer patients in Bangladesh

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

Roche Bangladesh CyberSecurity News & History

Roche Bangladesh Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Roche Bangladesh

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Roche Bangladesh vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - Roche Bangladesh (X = Date, Y = Severity)

Roche Bangladesh Subsidiaries

Roche Bangladesh

Roche Bangladesh Similar Companies

Hikma Pharmaceuticals

Dr. Reddy's Laboratories

MACLEODS PHARMACEUTICALS LTD.

Servier

AbbVie

Astellas Pharma

MSD

Parexel

Bristol Myers Squibb

Roche Bangladesh CyberSecurity News

Roche looks to serving more cancer patients in Bangladesh

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo